JKHY vs MBRX · P/E 30, rev $2.54B vs $8.2M cap
Jack Henry & Associates Inc (JKHY) versus Moleculin Biotech Inc (MBRX) — a side-by-side from cached financials, not a winner call.
Jack Henry & Associates Inc (JKHY) is a information technology services company listed on US.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
Latest reported JKHY revenue for 2026-06-30 was $2.54B. Net income was $502.8M. Revenue was up 7.1% from 2025-06-30 to 2026-06-30. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
JKHY currently screens at market cap $12.76B and trailing P/E 29.8. MBRX currently screens at market cap $8.2M.
Not investment advice. Open the JKHY and MBRX stock pages for the full models.
Not investment advice.